US | The Global Innovation Policy Center

Primary Sources

37 CFR Part 1 – Changes to Continued Prosecution Application Practice; Interim Rule (2014)

37 CFR Part 1 – Changes to Implement the Prioritized Examination for Requests for Continued Examination; Final Rule (2011)

37 CFR Part 1 – Changes to Implement the Supplemental Examination Provisions of the Leahy-Smith America Invents Act and to Revise Reexamination Fees; Final Rule (2012)

37 CFR Part 1 – Changes to Permit Delayed Submission of Certain Requirements for Prioritized Examination; Interim Rule (2014)

37 CFR Part 1 – Examination Guidelines for Implementing the First Inventor to File Provisions of the Leahy-Smith America Invents Act; Final Rule (2013)

37 CFR Part 1 – Revision of Patent Term Adjustment Provisions Relating to Appellate Review; Final Rules (2012)

37 CFR Part 1 – Revision of Standard for Granting an Inter Partes Reexamination Request; Final Rule (2011)

37 CFR Part 1- Revision of Patent Term Adjustment Provisions Relating to Information Disclosure Statements; Final Rule (2011)

37 CFR Part 1- Revisions to Implement the Patent Term Adjustment Provisions of the Leahy-Smith America Invents Act Technical Corrections Act; Final Rule (2014)

37 CFR Part 1- Revisions to Patent Term Adjustment; Interim Final Rule (2013)

37 CFR Part 6 – International Trademark Classification Changes, Final Rule (2012)

37 CFR Parts 1 – Changes to Implement the First Inventor to File Provisions of the Leahy-Smith America Invents Act; Final Rules (2013)

37 CFR Parts 1 – Changes to Implement the Patent Law Treaty; Final Rule; Correction (2013)

37 CFR Parts 1 & 41 – Rules of Practice Before the Board of Patent Appeals and Interferences in Ex Parte Appeals; Final Rule (2011)

37 CFR Parts 1, 3 & 11 – Changes to Implement the Patent Law Treaty; Final Rules (2013)

37 CFR Parts 1, 41 & 42 – Setting and Adjusting Patent Fees; Final Rule (2013)

37 CFR Parts 1, 5, 10, 11 & 41 – Changes to Implement Miscellaneous Post Patent Provisions of the Leahy- Smith America Invents Act; Final Rule (2012)

37 CFR Parts 2 and 7 – Changes in Requirements for Specimens and for Affidavits or Declarations of Continued Use or Excusable Nonuse in Trademark Cases; Final Rule (2012)

47 CFR – Telecommunication(Revised as of October, 2010) (2010)

Act to Amend the Trademark Act of 1946 to Correct an Error in the Provisions Relating to Remedies for Dilution (Public Law 112-190, 126 Stat. 1436) (2012)

Act to Correct and Improve Certain Provisions of the Leahy-Smith America Invents Act and Title 35, United States Code (Public Law No. 112-274, 126 Stat. 2456) (2013)

America Competes Act (Public Law 110-69, 121 Stat. 572) (2007)

America Competes Reauthorization Act of 2010 (Public Law 111-358, 124 Stat. 3982) (2011)

Biologics Price Competition and Innovation Act of 2009 (Public Law 111–148, 124 Stat. 119) (2009)

Code of Federal Regulations, Title 19, Customs Duties (Revised as of April 1, 2012) (2012)

Code of Federal Regulations, Title 37, Subchapter A-Copyright Office and Procedures, Part 201, and Subchapter B-Copyright Arbitration Royalty Panel Rules and Procedures, Part 253 (2012)

Communications Act of 1934, Title 47 U.S.C., Section 151 et. seq (as amended through Public Law 112–96, enacted February 22, 2012) (2013)

Computer Fraud and Abuse Act of 1986, 18 U.S.C. § 1030 (2009)

Consolidated Antitrust Laws from the United States Code, 15 U.S.C §§ 1-7 (Sherman Act); 15 U.S.C. §§ 12-27 and 29 U.S.C. §§ 52-53 (Clayton Act); 15 U.S.C. §§ 41-58 (The Federal Trade Commission Act); 15 U.S.C. § 13 (Robinson-Patman Act) (2010)

Defend Trade Secrets Act of 2016 (Public Law No. 114-153) (2016)

Disclosure of Information for Certain Intellectual Property Rights Enforced at the Border (2012)

Dot Kids Implementation and Efficiency Act Of 2002 (Public Law 107, 116 Stat. 2766) (2002)

Economic Espionage Act of 1996, 18 U.S.C. §§ 1831 et seq. (2008)

Extension of the Patent Application Backlog Reduction Stimulus Plan; Notice (2010)

Extension of the Period for Comments on the Enhancement of Quality of Software Related Patents; Notice (2013)

Family Entertainment and Copyright Act of 2005 (Public Law 109-9, 119 Stat. 218) (2005)

Food and Drug Administration Amendments Act of 2007 (Public Law 110-85, 121 Stat. 823) (2007)

Food, Conservation, and Energy Act of 2008 (Public Law 110-246, 122 Stat. 1651) (2008)

Glossary Pilot Program; Notice (2014)

Homeland Security Act of 2002 (Public Law 107, 116 Stat. 2135) (2002)

Individuals with Disabilities Education Improvement Act of 2004 (Public Law 108-446, 118 Stat. 2647) (2004)

Intellectual Property Protection and Courts Amendments Act of 2004 (Public Law 108-482, 118 Stat. 3912) (2004)

Leahy-Smith America Invents Act (AIA) (2011)

Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Public Law 108-173, 117 Stat. 2066) (2003)

National Defense Authorization Act for Fiscal Year 2012 (2011)

National Stolen Property Act of 1948, 18 U.S.C. § 2314 (2009)

Notice of Forum on the Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena, and Natural Products; Notice of Public Meeting (2014)

Patent Law Treaties Implementation Act of 2012 (Public Law 112–211, 126 Stat. 1527) (2012)

Prioritizing Resources and Organization for Intellectual Property Act of 2008 (Public Law 110-403, 122 Stat. 4256) (2008)

Quick Path Information Disclosure Statement (QPIDS) Pilot Program (2012)

Rules of Practice in Patent Cases, 37 C.F.R. 1 (Consolidated Patent Rules as of May 2014) (2014)

Satellite Television Extension and Localism Act of 2010 (2010)

Satellite Television Extension and Localism Act of 2010 (Public Law No. 111-175) (2010)

Section 355 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.§ 355 (2010)

Small Business Act (as amended through Public Law 113–76, 128 Stat. 5 on January 17, 2014) (2014)

Small Webcaster Settlement Act of 2002 (Public Law 107-321, 116 Stat. 2780) (2002)

Stevenson – Wydler Technology Innovation Act of 1980, as amended through America Competes Reauthorization Act of 2010 (Public Law 111-358, 124 Stat. 3982), 2011 (2011)

Supplementary Examination Guidelines for Determining Compliance with 35 U.S.C. 112 and for Treatment of Related Issues in Patent Applications (2011)

The Biologics Price Competition and Innovation Act of 2009 (the BPCI Act) (2010)

The Patient Protection and Affordable Care Act, of March 23, 2010 (2010)

Title 15 – Commerce and Trade, 2000 Edition, Supplement 1 (Effective as of January 22, 2002) (2001)

Trademark Dilution Revision Act of 2006 (Public Law 109-312, 120 Stat. 1730) (2006)

Trademark Technical and Conforming Amendment Act of 2010 (Public Law No. 111-146, 124 Stat. 66, 2010) (2010)

U.S. Copyright Act of 1976, 17. U.S.C. §§ 101 et seq. (consolidated version of December 2011) (2011)

U.S. Crimes and Criminal Procedure, 18 U.S.C. §§ 1 et seq. (2013)

U.S. Patent Law, 35 U.S.C. §§ 1 et seq. (consolidated as of May 2015) (2015)

U.S. Trademark Law: Rules of Practice in Trademark Cases, 37 C.F.R. 2 et seq. & Federal Statues; Trademark Act, 15 U.S.C. §§ 1051 et seq. & Patent Act, 35 U.S.C. Part 1 (Consolidated Trademark Law and Regulation as of July 11, 2015) (2015)

United States – Korea Free Trade Agreement Implementation Act (2011)

United States– Panama Trade Promotion Agreement Implementation Act (Public Law 112-43, 125 Stat. 497) (2011)

United States–Colombia Trade Promotion Agreement Implementation Act (2011)

Unlocking Consumer Choice and Wireless Competition Act (Public Law 113-144, 128 Stat. 1751), 2014 (2014)

Webcaster Settlement Act of 2008 (Public Law 110-435, 122 Stat.4974) (2008)

Work Made for Hire and Copyright Corrections Act of 2000 (Public Law 106-379, 114 Stat.1444) (2000)

Secondary Sources

AIPPI (2016), “Report Standing Committee on Subcommittee Biotechnology”, 8/3/2016

Bell, J. (2016), “Pharma PTAB Petitions Jump As Firms Test New Forum”, Law260

Bloomberg BNA (2015), “Any Chance of Notice and Takedown Reform?”, 7/24/2016

Bloomberg BNA (2016), “Second Amgen Biosimilar Decision Provides More Clarity”, 7/7/2016

Borella, M. (2016), “McRO, Inc. v. Bandai Namco Games America Inc. (Fed. Cir. 2016)”, Patent Docs, 9/13/2016

Brennan, Z. (2016), “BIO Opposes House Bill to Reduce Biologics Exclusivity From 12 to 7 Years”, RAPS, 6/23/2016

Brinckerjoff, C. (2016), “CAFC Finds Cryopreservation Method Patent Eligible”, Pharma Patents Blog, 7/7/2016

Brinckerjoff, C. (2016), “Supreme Court Deals Blow To Diagnostic Method Patents, Denies Cert In Sequenom”, Pharma Patents Blog, 6/9/2016

Brinckerjoff, C. & Elliott, S. (2016), “Apotex Biosimilar Cleared Of Infringement But Pre- Marketing Notice Still Required”, Pharma Patents Blog, 9/15/2016

BSA Press Release (2016), “The Software Alliance Applauds Federal Circuit’s Confirmation that Innovative Software is Patentable”, 9/13/2016

Chung, A. (2016), “Supreme Court Weighs How to Figure Design Patent Damages in iPhone Case”, Insurance Journal, 10/18/2016

Comments of the Pharmaceutical Research and Manufacturers of America on the PTO’s Request for Comments on Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board, Docket No.PTO-P-2015-0053, 11/18/2015

Crouch, D. (2016), “New Guidance to Examiners: Follow Enfish and TLI”, PatentlyO, 5/19/2016

Department of Commerce/USPTO (2015), “DMCA Notice-and-Takedown Processes: List of Good, Bad, and Situational Practices”

DLA Piper (2016), “Obama signs federal trade secret bill into law: key points for IP”, 5/11/2016

Docket Report (2016), “PTAB Analytics Indicate Record Highs for Bio/Pharma IPR/PGR Institution Rates”, 11/2/2016

Executive Office of the President, Office of Management and Budget (2016), “Memorandum for the Heads of Departments and Agencies, “Category Management Policy 16-1: Improving the Acquisition and Management of Common Information Technology: Software Licensing” 6/2/2016

Finnegan (2015), “Federal Circuit Decision in Ariosa v. Sequenom Offers Further Clarification on the Scope of Patent Eligible Subject Matter”, 6/23/2015

Goldsten, D. et al (2016), “FTC And DOJ Antitrust Division Request Comments On Proposed Revisions To Antitrust Guidelines For Licensing IP”, IP Frontline, 8/24/2016

Graham, S. (2016), “Federal Circuit Softens Stance on Patent Eligibility”, National Law Journal, 11/2/2016

Hall, C. (2016), “Federal Judge Says Alice ‘Death Knell for Software Patents'”, Dev Pro Connections, 10/12/2016

Hurley, L. (2016), “Supreme Court Upholds Quick Patent Cancellation Process in Speedometer Case”, Insurance Journal, 6/20/2016

ICLG (2016), “U.S. Supreme Court Reaffirms Flexible Analysis for Enhanced Damages in U.S. Patent Cases”, ICLG Patents 2017, 8/24/2016

Joint Comments of American Association of Independent Music et al(2015), In the Matter of Section 512 Study: Notice and Request for Public Comment, Docket No.2015-7, Before the US Copyright Office

Jones Day (2016), “Obviousness in Inter Partes Review Proceedings”, February 2016

Lexology (2016), “A New Hope for Software Patents?”, 6/2/2016

Lexology (2016), “FRAND and SEPs in the United States”, 5/23/2016

Lexology (2016), “What is Up with Patent Reform, and What About Those Darn Trolls?”, 3/11/2016

Little, T. (2015), “Etsy fights back against allegations that it is “a go-to destination for counterfeits””, World Trademark Review, 7/15/2015

Little, T. (2015), “Online platforms issue joint call for safe harbour to allow challenges to “spurious assertion of trademark rights””, World Trademark Review, 10/19/2015

Llewellyn, P. (2016), “”UNITED STATES: Trade Facilitation and Trade Enforcement Act of 2015 Strengthens Enforcement of IP Rights at U.S. Borders””, INTA Bulletin, Vo.71, No.13, 8/1/2016

Loney, M. (2016), “Federal Circuit Falling Behind as PTAB Appeals Stack Up”, Managing IP, 11/1/2016

Loney, M. (2016), “PTAB 4 years in: Hedge funds and reverse patent trolls”, Managing IP, 9/9/2016

Morrow, C. & Mehta, S. (2016), “Supreme Court to Weigh in on Damages for Design Patent Infringement”, IPWatchdog, 5/24/2016

Mudge, B. & Plavsic, D. (2016), “Federal Circuit Rules on Burden to Establish Patentability of Amended Claims”, Inter Partes Review Blog, 3/22/2016

Mueller, L. (2014), “The Thorny Problem of Patentable Eligible Subject Matter: Part 1 of a 10-Part Series: U.S”, 4/30/2014

Oblon, (2011), “The Enactment of the America Invents Act Brings a Variety of Post Grant Options to U.S. Patent Law”, October 2011

Pharm Patents Blog (2016), “USPTO Patent Eligibility Guidance In View Of CellzDirect And Sequenom”, 7/18/2016

Quinn, G. (2016), “USPTO issues new memorandum on software eligibility in light of McRo, BASCOM”, IPWatchdog, 11/2/2016

Ramage, W.E. (2016), “Inter partes review burden of proof does not shift to patent owners”, Intellectual Asset Management International report, 8/3/2016

Roberts, J.J. (2016), “”Tech Industry Wins Big in Supreme Court Patent Ruling””, Fortune.com, 6/20/2016

Ryan, J. (2015), “Solving the government’s software licensing problem”, Federal Scoop, 2/20/2015

Shah, A. & Armington, N. (2015), “ClearCorrect v. ITC: Federal Circuit Hears Argument in Case Which Will Decide Whether ITC Has Jurisdiction Over Digital Imports”, Global IP Matters, 8/12/2015

Shapiro (2016), “Obama sings the Trade Facilitation and Trade Enforcement Act into Law”, 2/2/6/2016

Sintich, S. (2016), “Status Report on IPR Statistics for the Biotech/Pharma Technology Center”, PTABWatch, 7/11/2016

Tibken, S. (2016), “Supreme Court grills Apple, Samsung over value of design patents”, CNET.com, 10/11/2016

Turchyn, J. (2016), “Improving Patent Quality Through Post-Grant Claim Amendments: A Comparison of European Opposition Proceedings and U.S. Post-Grant Proceedings”, Michigan Law Review, Vol.114, Iss.8

US Customs and Border Protection (2016), “Trade Facilitation and Trade Enforcement Act of 2015—Overview”

USPTO (2014), “2014 Interim Eligibility Guidance Quick Reference Sheet”

USPTO (2015), July 2015 Update Appendix 3: Subject Matter Eligibility Court Decisions”

USPTO (2016), “Memorandum from Robert W. Bahr: Recent Subject Matter Eligibility Decisions”, 11/2/2016

USPTO (2016), “Patent Trial and Appeal BoardStatistics”, 9/30/2016

WSJ (2015), “Oracle gains win over Google at Supreme Court”, 6/29/2015

Young, D. & Colantonio, J. (2016), “USPTO Provides Updates to Patent Subject Matter Eligibility Guidance”, IPWatchdog, 6/1/2016

The Global Innovation Policy Center U.S. Chamber of Commerce 1615 H Street, NW Washington, DC 20062

202-463-5601

gipc@uschamber.com

All media inquiries:
Please contact Scott Hall at smhall@uschamber.com or 202-463-5817.